https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accounts-payable-other-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/acquired-intangibles https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/acquisition-bargain-purchase-gain-recognized-amount https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/advances-on-inventory-purchases https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-recoveries https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/assets-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/assets-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/commitments-and-contingencies https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/construction-in-progress-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/contractual-obligation https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/customers-liability-for-acceptances-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/debt-collateral-amount https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-compensation-equity https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-other-loss-carryforwards https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deposit-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deposit-contracts-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/due-from-customer-acceptances https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/escrow-deposit-disbursements-related-to-property-acquisition https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/income-taxes-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/increase-decrease-in-prepaid-taxes https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/interest-receivable-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/land https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/loans-payable-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/loans-receivable-net https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/marketing-and-advertising-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/nonoperating-gains-losses https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-amortization-of-deferred-charges https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-commitment https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-deferred-cost-amortization-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-income-2 https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-inventory-in-transit https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-noncash-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-noncash-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-receivables https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-receivables-net-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-significant-noncash-transaction-value-of-consideration-given https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-for-construction-in-process https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-for-other-deposits https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-assets-investing-activities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-land-held-for-use https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-advertising https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-current-and-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/prepaid-taxes https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-collection-of-loans-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-collection-of-notes-receivable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-interest-received https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-other-deposits https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-sale-of-other-productive-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/property-plant-and-equipment-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/provision-for-loan-losses-expensed https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/receivables-fair-value-disclosure https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/retained-earnings-appropriated https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/sales-commissions-and-fees https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/sales-discounts-goods https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/sales-discounts-returns-and-allowances-goods https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/selling-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shares-issued-for-stock-awards https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/short-term-borrowings https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/short-term-non-bank-loans-and-notes-payable https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/shortterm-debt-fair-value https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-outstanding-change https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tangible-asset-impairment-charges https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/taxes-payable-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/biostar-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted